Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial
Andrew R. Hoffman(VA Palo Alto Health Care System), Mary Lee Vance(University of Virginia), Janet Schlechte(University of Iowa), Michael O. Thorner(University of Virginia), Howard B. A. Baum(Harvard University), Lawrence S. Phillips(University at Buffalo, State University of New York), David L. Kleinberg(New York University), Richard V. Clark(Duke Medical Center), Richard J. Robbins(Yale University), Beverly M. K. Biller(Harvard University), David M. Cook, E. Chester Ridgway(Boston University), Gerhard Baumann(Northwestern University), Joyce Baptista, Anne Klibanski(Harvard University), Silvio E. Inzucchi(Yale University), Meeta Sharma(George Washington University), Joyce Kuntze
Cited by 185
Related Papers
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
|New England Journal of Medicine|2015|11.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
|Diabetes Care|2012|3.2k
The Colorado Thyroid Disease Prevalence Study
|Archives of Internal Medicine|2000|2.8k